Salient Capital Advisors’s Johnson & Johnson JNJ Stock Holding History
Bought
Maintained
Sold
Other funds holding JNJ
Salient Capital Advisors's JNJ Position: Q3 2017 in Review
Salient Capital Advisors sold out of Johnson & Johnson (JNJ) in Q3 2017, closing a stake of 86,138 shares — an estimated $11.4M sold.
Salient Capital Advisors first reported a position in JNJ in Q2 2013 and held it in 17 quarters. The position peaked at $11.4M in Q2 2017. 2,356 funds tracked by Wall St. Rank hold JNJ as of Q3 2017.
- Salient Capital Advisors reported no remaining Johnson & Johnson position as of Q3 2017 after selling out during the quarter.
- Salient Capital Advisors sold 86,138 Johnson & Johnson shares in Q3 2017, an estimated $11.4M.
- Salient Capital Advisors first reported a position in Johnson & Johnson in Q2 2013 and held it in 17 quarters.
- Salient Capital Advisors's Johnson & Johnson position peaked at $11.4M in Q2 2017.
- 2,356 funds tracked by Wall St. Rank held Johnson & Johnson as of Q3 2017.
Based on Salient Capital Advisors's 13F filing for Q3 2017, filed 6 Nov 2017.